ICU MEDICAL INC/DE Cost of Revenue
ICU MEDICAL INC/DE (ICUI) reported Cost of Revenue of $316.63 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Cost of Sales
us-gaap:CostOfRevenue · last filed 2026-08-06
- ICU MEDICAL INC/DE cost of revenue for the quarter ending 2026-06-30 was $316.63M, a 7.09% decline year-over-year.
- ICU MEDICAL INC/DE cost of revenue for the quarter ending 2026-03-31 was $324.00M, a 17.89% decline year-over-year.
- ICU MEDICAL INC/DE cost of revenue for the quarter ending 2025-09-30 was $336.11M, a 12.54% decline year-over-year.
- ICU MEDICAL INC/DE cost of revenue for the quarter ending 2025-06-30 was $340.80M, a 12.40% decline year-over-year.
- ICU MEDICAL INC/DE cost of revenue for fiscal 2018 was $830.01M.
| Period end | Cost of Revenue 3 month | Cost of Revenue 6 month | Cost of Revenue 9 month | Cost of Revenue 12 month |
|---|---|---|---|---|
| 2026-06-30 | $316.63M 10-Q · filed 2026-08-06 | $640.63M 10-Q · filed 2026-08-06 | ||
| 2026-03-31 | $324.00M 10-Q · filed 2026-05-07 | |||
| 2025-09-30 | $336.11M 10-Q · filed 2025-11-06 | $676.91M derived: sum of 2 quarters · filed 2026-08-06 | $1.07B 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $340.80M 10-Q · filed 2026-08-06 | $735.39M 10-Q · filed 2026-08-06 | ||
| 2025-03-31 | $394.59M 10-Q · filed 2026-05-07 | |||
| 2024-09-30 | $384.28M 10-Q · filed 2025-11-06 | $773.31M derived: sum of 2 quarters · filed 2025-11-06 | $1.15B 10-Q · filed 2025-11-06 | |
| 2024-06-30 | $389.03M 10-Q · filed 2025-08-07 | $770.44M 10-Q · filed 2025-08-07 | ||
| 2024-03-31 | $381.41M 10-Q · filed 2025-05-08 | |||
| 2023-09-30 | $369.39M 10-Q · filed 2024-11-12 | $726.37M derived: sum of 2 quarters · filed 2024-11-12 | $1.10B 10-Q · filed 2024-11-12 | |
| 2023-06-30 | $356.98M 10-Q · filed 2024-08-07 | $733.59M 10-Q · filed 2024-08-07 | ||
| 2023-03-31 | $376.61M 10-Q · filed 2024-05-07 | |||
| 2022-09-30 | $411.46M 10-Q · filed 2023-11-06 | $804.87M derived: sum of 2 quarters · filed 2023-11-06 | $1.18B 10-Q · filed 2023-11-06 | |
| 2022-06-30 | $393.41M 10-Q · filed 2023-08-07 | $767.71M 10-Q · filed 2023-08-07 | ||
| 2022-03-31 | $374.30M 10-Q · filed 2023-05-09 | |||
| 2021-09-30 | $208.27M 10-Q · filed 2022-11-07 | $406.42M derived: sum of 2 quarters · filed 2022-11-07 | $611.78M 10-Q · filed 2022-11-07 | |
| 2021-06-30 | $198.15M 10-Q · filed 2022-08-09 | $403.51M 10-Q · filed 2022-08-09 | ||
| 2021-03-31 | $205.37M 10-Q · filed 2022-05-09 | |||
| 2020-09-30 | $204.64M 10-Q · filed 2021-11-05 | $401.74M derived: sum of 2 quarters · filed 2021-11-05 | $608.93M 10-Q · filed 2021-11-05 | |
| 2020-06-30 | $197.09M 10-Q · filed 2021-08-04 | $404.29M 10-Q · filed 2021-08-04 | ||
| 2020-03-31 | $207.19M 10-Q · filed 2021-05-07 | |||
| 2019-09-30 | $188.92M 10-Q · filed 2020-11-06 | $397.33M derived: sum of 2 quarters · filed 2020-11-06 | $592.96M 10-Q · filed 2020-11-06 | $798.70M derived: sum of 4 quarters · filed 2020-11-06 |
| 2019-06-30 | $208.41M 10-Q · filed 2020-08-10 | $404.04M 10-Q · filed 2020-08-10 | $609.78M derived: sum of 3 quarters · filed 2020-08-10 | $802.36M derived: sum of 4 quarters · filed 2020-08-10 |
| 2019-03-31 | $195.63M 10-Q · filed 2020-05-08 | $401.37M derived: sum of 2 quarters · filed 2020-05-08 | $593.95M derived: sum of 3 quarters · filed 2020-05-08 | $802.61M derived: sum of 4 quarters · filed 2020-05-08 |
| 2018-12-31 | $205.74M derived: 10-K 12 month − 10-Q 9 month · filed 2019-03-01 | $398.32M derived: sum of 2 quarters · filed 2019-11-12 | $606.98M derived: sum of 3 quarters · filed 2019-11-12 | $830.01M 10-K · filed 2019-03-01 |
| 2018-09-30 | $192.58M 10-Q · filed 2019-11-12 | $401.24M derived: sum of 2 quarters · filed 2019-11-12 | $624.27M 10-Q · filed 2019-11-12 | |
| 2018-06-30 | $208.66M 10-Q · filed 2019-08-09 | $431.69M 10-Q · filed 2019-08-09 | ||
| 2018-03-31 | $223.03M 10-Q · filed 2019-05-10 | |||
| 2017-09-30 | $231.64M 10-Q · filed 2018-11-09 | $633.88M 10-Q · filed 2018-11-09 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| HAEMONETICS CORP (HAE) | United States | $4.821B | 36.52 |
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |